Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bone marrow-derived mesenchymal stem cell concentrate
- Development stage
- Unknown
- Lead developer
- Green International University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Percutaneous
01
Overview
Bone marrow-derived mesenchymal stem cell concentrate is an autologous cell-based biologic therapy investigated for the treatment of chronic discogenic low back pain and lumbar spinal degeneration. The therapy involves harvesting mesenchymal stem cells (MSCs) from the patient's own bone marrow, typically via aspiration from the posterior iliac crest, followed by concentration and intradiscal injection. As a regenerative medicine approach, it leverages the multipotent, immunomodulatory, and anti-inflammatory properties of BM-MSCs to potentially stimulate disc repair and reduce local inflammation. This specific therapeutic approach is being evaluated by Green International University in Lahore, particularly in combination with specialized post-injection physical therapy protocols including myofascial release and isotonic exercises.
- Other names
- BM-MSC concentrateautologous bone marrow-derived mesenchymal stem cell concentratebone marrow mesenchymal stem cell concentrateBMAC
Beyond the preview
Go deeper on bone marrow-derived mesenchymal stem cell concentrate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bone marrow-derived mesenchymal stem cell concentrate.